Inhibition of IL-11 signalling has been shown to provide therapeutic benefit in models of arthritis, multiple sclerosis, neointimal hyperplasia, multiple fibrotic diseases, and gastrointestinal cancers9–11,13,17,20,21,24,41,42. Here, IL11 is linked to arthritic joint disease.